Assobiotec, nell'ambito delle attività del gruppo di lavoro Pmi, organizza un webinar con Matthew Gline, CFO di Roivant Sciences Ltd, che illustrerà le ultime novità riguardanti nuovi modelli di avvio e finanziamento di start-up e PMI biotecnologiche: "Trends in financing the innovation: why is Roivant Sciences disruptor for pharma-biotech industry?".
Appuntamento su Webex mercoledì 7 ottobre alle 14.
Le registrazioni saranno aperte fino a martedì 6 ottobre alle 12. Alla chiusura delle iscrizioni sarà inviato link e codice di accesso Webex.
Per approfondimenti, ecco un breve profilo di Matthew Gline
Matthew Gline has served as Chief Financial Officer of Roivant Sciences, Inc. since September 2017. Mr. Gline joined Roivant in March 2016 and previously served as Senior Vice President, Finance and Business Operations. From April 2014 to March 2016, he was a Vice President at Goldman Sachs, Fixed Income Digital Structuring, where he focused on technology and data strategy. Prior to Goldman Sachs, Mr. Gline was a co-founder of Fourthree, Inc., a risk analytics technology and consulting company. From 2008 to 2012, he served as Vice President at Barclays, Enterprise Risk Management Advisory, where he provided analysis for corporate clients related to capital markets access for financing and risk management. Mr. Gline earned his A.B. in Physics from Harvard University.